MC10

MC10, Inc. was a privately held health technology company based in Lexington, Massachusetts, focused on improving human health through digital solutions. The company reshaped rigid conventional electronics into thin, flexible devices able to stretch, bend and twist with the body, an approach it described as virtually invisible and conformal electronics. Its technology combined conformal BioStamp sensors with clinical analytics to derive insights from physiological data collected either in the home or in clinical settings.

The flagship product, BioStamp nPoint, was intended for the clinical research community and optimized for in-home use, consolidating the collection of physiological data and patient-reported outcomes for clinical trials. Product categorizations for the company spanned remote patient monitoring, wearables, sensors, mobile applications and predictive analytics/machine learning, serving patients and providers across hospital and other care settings with pharma as the principal buyer. Preqin classifies the company under semiconductors as a primary industry, with sub-industries including healthcare IT, medical devices and equipment, electronic components, semiconductor equipment and testing, and biomaterials.

In October 2020, Medidata, a wholly owned subsidiary of Dassault Systèmes, acquired MC10's digital biomarker business. The acquired offerings were positioned to add clinical analytics and biosensor capabilities to Medidata's Patient Cloud solutions in ePRO, eCOA and biomarker discovery, with the MC10 nPoint BioStamp incorporated alongside other mobile devices into Medidata's sensor data ingestion and analytics platform. Medidata's Sensors product line continues to offer continuous, medical-grade data capture combining objective digital measures with eCOA for clinical trials.

Founding story

Accounts of MC10's origins differ across sources. A company profile states that in 2008 John Rogers, a founder of MC10, set out to redefine the boundaries between humans and electronics, and that the stretchable electronics he and his team developed became the technological groundwork for MC10's research and medical products. Preqin's profile states the company was founded in 2008 by Roozbeh Ghaffari and headquartered in Lexington, US. Ben Schlatka is identified as a co-founder and, at the time of the 2020 acquisition, chief executive officer.

Business model

MC10 supplied wearable sensor hardware and accompanying clinical analytics to the clinical research market, with pharmaceutical organizations identified as the primary buyer of its digital health products. Preqin describes revenue as generated through partnerships and sales of its wearable technologies under long-term client agreements, with subscription-based pricing for access to the technology.

Per Preqin, revenue came from partnerships and sales of wearable technologies, typically under long-term agreements with subscription-based pricing for access to the technology.

Latest developments

On October 27, 2020, Medidata acquired MC10's digital biomarker business for undisclosed terms, bringing the nPoint BioStamp and MC10's clinical analytics into Medidata's Patient Cloud portfolio. Preqin records this as MC10's most recent deal and lists the company stage as acquired.